Home / Reports / Longevity UK

Market report · Edition 5 · Jul 2026

UK Longevity Clinics: Market Entry Report

Competition, pricing, regulation, geography and unit economics for new entrants in private longevity and preventive-health clinics — biomarker diagnostics, epigenetic clocks, full-body MRI, IV/NAD+, functional and concierge medicine and membership programmes. Decision-grade, with an ED5 decision simulator up front.

UK · 2025–2026 · Edition 5ED5 decision simulator (members × ticket)Unit-economics model and break-evenVoices from the sector

€299/ individual licence

Instant-download PDF, with an ED5 decision simulator an investor reads first
A unit-economics model (members × ticket), a line-by-line P&L and the break-even
Bimodal CAPEX (£150k–£450k membership clinic vs £1.3m–£3.5m+ with in-house imaging) and the partner-out-MRI thesis
The regulatory spine: the CQC gate, VAT-exemption as an advantage, peptides as a red line and whole-body-MRI overdiagnosis
Voices from the sector, sources cited with confidence level, and practical templates

Buy and download Download free sample

Secure payment · Automatic delivery to your email

What's included

From market to decision

Each section answers a concrete question an investor or operator asks before committing capital.

A market with no dominant brand and no audited size

No leading national operator and no audited market figure — the envelope is UK private acute healthcare (£13.8bn in 2024): the white space is a CQC-registered, doctor-led membership clinic in an affluent-underserved catchment.

The unit-economics engine

A members × ticket model, bimodal CAPEX (£150k–£450k for a membership clinic vs £1.3m–£3.5m+ with in-house MRI), a worked P&L and the break-even.

Where to open: geography and formats

The winning play is a membership clinic in an affluent-but-underserved postcode (Elmbridge, the Cheshire Golden Triangle, Wimbledon/Richmond), partnering out MRI rather than buying in-house imaging.

Regulation as the moat

CQC registration as the entry gate, VAT-exemption as an advantage over cosmetic aesthetics at 20% VAT, peptides as a red line and whole-body-MRI overdiagnosis.

Contents

Sections + annexes

01 ED5 Decision Simulator (thesis, members × ticket, break-even, risks, 30-day sprint)

02 Market and Consumer

03 Geography and Formats

04 Competitive Landscape (Neko Health, HUM2N, Lanserhof, Echelon, Cleveland Clinic London)

05 Unit Economics (members × ticket and bimodal CAPEX)

06 P&L and Decision Simulator

07 Regulation (CQC, VAT, peptides, whole-body MRI)

A Operations and Annexes

Preview

A look inside

Professional design, verified data and clear charts in every section.

A sample of pages from the report. The full version includes all tables, charts and sources.

Clear pricing

The analysis you need, at an accessible price

Premium sector report

USD 2,000–4,750

Extensive reports focused on market size and its evolution, with deep macro-level detail.

Bioy Research report

€299

Decision-focused analysis: competitive map, density by city, economics and entry insight.

Bespoke study

€1,500–6,000

Tailored analysis for one specific site, with an on-site visit and a custom quote.

Frequently asked

Before you buy

What format do I receive?

A PDF ready to read on any device or to print. You receive it by email immediately after payment.

What currency is the data in?

Economic figures are expressed in pounds sterling (£), with a US dollar (USD) equivalent only where it helps the reading.

Is it UK-specific?

Yes. The analysis, regulation (CQC, VAT), geography and unit economics focus entirely on the UK market.

What language is the report in?

This report is available in English, and also in Spanish, German and French.